A Multicenter Randomized Double Blind Study Examining the Efficacy and Safety of Denosumab in Combination With First Line Platinum-based Chemotherapy for Patients With Bone Metastasis Secondary to Metastatic Urothelial Cancer
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2018
Price : $35 *
At a glance
- Drugs Denosumab (Primary) ; Calcium; Carboplatin; Cisplatin; Gemcitabine; Vitamin D
- Indications Bladder cancer; Bone metastases; Renal cancer; Ureteral neoplasms; Urogenital cancer
- Focus Biomarker; Pharmacodynamics
- Acronyms DENIM
- 17 Sep 2018 Status changed from not yet recruiting to recruiting.
- 13 Aug 2018 Planned initiation date changed from 1 Jun 2018 to 1 Sep 2018.
- 11 May 2018 New trial record